ACRS 8-K 2026-10-27

Aclaris Therapeutics, Inc. (ACRS) 8-K dated 2026-10-27 — accession 0001104659-26-119231. This URL is the filing, not the ACRS hub.

Aclaris Therapeutics, Inc. (ACRS) is a biotechnology company listed on NASDAQ.

Aclaris Therapeutics, Inc. filed a 8-K on 2026-10-27. Accession 0001104659-26-119231.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ACRS revenue for 2025-12-31 was $7.8M. Net income was -$64.9M. Revenue was down 58.2% from 2024-12-31 to 2025-12-31. ACRS currently screens at market cap $615.9M.

Not investment advice. The ACRS SEC hub lists recent forms. The stock page is the research view.